concept

TAU PATHOLOGY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1265Connections

0Hypotheses

12Analyses

50Outgoing

50Incoming

Summary

TAU PATHOLOGY is a concept in neurodegeneration research. Key relationships include: activates, biomarker for, therapeutic target. Associated with ALS, Aging, Als. Connected to 600 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	TAU PATHOLOGY
Key Genes/Proteins	ALZHEIMER'S DISEASE, MICROGLIA
Related Diseases	Alzheimer, Als, Aging, Neurodegeneration
Linked Hypotheses	1 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

→

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

→

Corticobasal Syndrome (CBS)

disease · 11374 words

→

Pathway Diagram

graph TD
    TAU_PATHOLOGY["TAU PATHOLOGY"]
    TAU_PATHOLOGY -->|"activates"| neurodegeneration["neurodegeneration"]
    TAU_PATHOLOGY -->|"causes"| synapse_loss["synapse loss"]
    TAU_PATHOLOGY -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    TAU_PATHOLOGY -->|"activates"| inflammatory_responses["inflammatory responses"]
    TAU_PATHOLOGY -->|"activates"| neuroinflammation["neuroinflammation"]
    TAU_PATHOLOGY -.protects against.-> Alzheimer["Alzheimer"]
    autophagy_dysfunction["autophagy dysfunction"] -->|"activates"| TAU_PATHOLOGY
    necroptosis["necroptosis"] -->|"activates"| TAU_PATHOLOGY
    MHC_I["MHC-I"] -->|"activates"| TAU_PATHOLOGY
    APOE["APOE"] -->|"regulates"| TAU_PATHOLOGY
    ApoE4["ApoE4"] -->|"contributes to"| TAU_PATHOLOGY
    TREM2["TREM2"] -->|"regulates"| TAU_PATHOLOGY
    APOE3["APOE3"] -->|"regulates"| TAU_PATHOLOGY

Outgoing (694)

Target	Relation	Type	Str
Alzheimer	therapeutic_target	disease	1.00
Alzheimer	biomarker_for	disease	1.00
Alzheimer	activates	disease	1.00
Als	associated_with	disease	1.00
Alzheimer	associated_with	disease	1.00
Aging	associated_with	disease	1.00
Alzheimer	regulates	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Neurodegeneration	activates	disease	1.00
Als	biomarker_for	disease	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
MICROGLIA	activates	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
Alzheimer	protects_against	disease	0.95
Neurodegeneration	inhibits	disease	0.95
Aging	therapeutic_target	disease	0.95
Als	therapeutic_target	disease	0.95
Neurodegeneration	regulates	disease	0.95
Inflammation	regulates	disease	0.95
Neuroinflammation	regulates	disease	0.95
Als	activates	disease	0.95
Aging	activates	disease	0.95
GFAP	biomarker_for	gene	0.90
ALZHEIMER'S DISEASE	biomarker_for	gene	0.90
Alzheimer	inhibits	disease	0.85
Tauopathy	therapeutic_target	disease	0.85
Inflammation	therapeutic_target	disease	0.85
Dementia	biomarker_for	disease	0.85
Neuroinflammation	activates	disease	0.85
Dementia	associated_with	disease	0.85
Neuroinflammation	associated_with	disease	0.85
Inflammation	associated_with	disease	0.85
NEUROINFLAMMATION	activates	gene	0.80
NEUROINFLAMMATION	regulates	gene	0.80
APOE4	activates	gene	0.80
ALZHEIMER'S DISEASE	expressed_in	gene	0.80
APOE	regulates	gene	0.80
ASTROCYTES	activates	gene	0.80
NEUROINFLAMMATION	associated_with	gene	0.80
ALZHEIMER'S DISEASE	protects_against	gene	0.80
Als	inhibits	disease	0.75
Inflammation	protects_against	disease	0.75
Neuroinflammation	protects_against	disease	0.75
Alzheimer	expressed_in	disease	0.75
Neurodegeneration	expressed_in	disease	0.75
Neuroinflammation	therapeutic_target	disease	0.75
Aging	biomarker_for	disease	0.75
Inflammation	activates	disease	0.75
Inflammation	inhibits	disease	0.75

Incoming (571)

Source	Relation	Type	Str
NEURODEGENERATION	associated_with	gene	1.00
TAU	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
AMYLOID	associated_with	gene	1.00
TAU	associated_with	gene	1.00
TAU	inhibits	gene	1.00
ALZHEIMER	associated_with	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
AMYLOID	activates	gene	1.00
TAU	regulates	gene	1.00
NEURODEGENERATION	inhibits	gene	0.90
AMYLOID	biomarker_for	gene	0.90
ALZHEIMER	biomarker_for	gene	0.90
NEURODEGENERATION	activates	gene	0.90
MHC-I	associated_with	gene	0.85
ALZHEIMER	expressed_in	gene	0.80
ALZHEIMER	regulates	gene	0.80
ALZHEIMER	inhibits	gene	0.80
NEURODEGENERATION	regulates	gene	0.80
TAU	implicated_in	gene	0.80
AMYLOID	therapeutic_target	gene	0.80
TAU	therapeutic_target	gene	0.80
TAU	biomarker_for	gene	0.80
ALZHEIMER	protects_against	gene	0.80
LDLR	inhibits	gene	0.70
APOE3	protects_against	gene	0.70
PSEN1	protects_against	gene	0.70
NEURODEGENERATION	expressed_in	gene	0.70
MITOPHAGY	inhibits	gene	0.70
NEURODEGENERATIVE DISEASES	biomarker_for	gene	0.70
ALZHEIMER'S DISEASE	activates	gene	0.70
INFLAMMATION	inhibits	gene	0.70
ALZHEIMER'S DISEASE	regulates	gene	0.70
AMYLOID	causes	gene	0.70
TAU	expressed_in	gene	0.70
TAU	contributes_to	gene	0.70
INFLAMMATION	biomarker_for	gene	0.70
APOPTOSIS	therapeutic_target	gene	0.70
NEURODEGENERATION	therapeutic_target	gene	0.70
FERROPTOSIS	therapeutic_target	gene	0.70
INFLAMMATION	therapeutic_target	gene	0.70
DEMENTIA	associated_with	gene	0.70
AMYLOID	implicated_in	gene	0.70
AMYLOID	regulates	gene	0.70
AMYLOID	contributes_to	gene	0.70
TAU	protects_against	gene	0.70
ALZHEIMER'S DISEASE	protects_against	gene	0.60
APOE3	inhibits	gene	0.60
ALZHEIMER'S DISEASE	inhibits	gene	0.60
APOE4	activates	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (12)

Scientific analyses that reference this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

TAU PATHOLOGY

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Pathway Diagram

Outgoing (694)

Incoming (571)

Targeting Hypotheses (0)

Mentioning Analyses (12)

What molecular mechanisms underlie the dose-dependent protective effects of the

Does tau aggregation specifically cause PS externalization in vesicles independe

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Trans-synaptic tau spreading and propagation mechanisms in AD

Investigate prion-like spreading of tau pathology through connected brain region

Tau propagation mechanisms and therapeutic interception points

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Related Papers (0)

TAU PATHOLOGY

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

primary-progressive-aphasia

CBS/PSP Supplements Guide

Atypical Parkinsonism

Device Therapies Comparison for CBS/PSP

Parthanatos in Neurodegeneration

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome

Alzheimer's Disease Mechanism Index

Corticobasal Degeneration (CBD)

nhp-validation-animal-model

Pathway Diagram

Outgoing (694)

Incoming (571)

Targeting Hypotheses (0)

Mentioning Analyses (12)

What molecular mechanisms underlie the dose-dependent protective effects of the

Does tau aggregation specifically cause PS externalization in vesicles independe

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Trans-synaptic tau spreading and propagation mechanisms in AD

Investigate prion-like spreading of tau pathology through connected brain region

Tau propagation mechanisms and therapeutic interception points

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidi

Related Papers (0)